# Lurasidone Effects on Tissue Glutamate in Schizophrenia

> **NCT02199743** · PHASE4 · COMPLETED · sponsor: **University of Texas Southwestern Medical Center** · enrollment: 35 (actual)

## Conditions studied

- Schizophrenia
- Schizoaffective Disorder

## Interventions

- **DRUG:** Lurasidone
- **DRUG:** Haloperidol
- **DRUG:** Perphenazine

## Key facts

- **NCT ID:** NCT02199743
- **Lead sponsor:** University of Texas Southwestern Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-02
- **Primary completion:** 2016-06
- **Final completion:** 2016-06
- **Target enrollment:** 35 (ACTUAL)
- **Last updated:** 2021-03-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02199743

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02199743, "Lurasidone Effects on Tissue Glutamate in Schizophrenia". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02199743. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*